{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:53:59Z","timestamp":1791960839374,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,12]],"date-time":"2010-10-12T00:00:00Z","timestamp":1286841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,10,12]],"date-time":"2010-10-12T00:00:00Z","timestamp":1286841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11940-010-0098-1","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T12:47:57Z","timestamp":1286974077000},"page":"79-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Herpes Zoster Ophthalmicus"],"prefix":"10.1007","volume":"13","author":[{"given":"Srinivasan","family":"Sanjay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philemon","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavan","family":"Lavanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,12]]},"reference":[{"key":"98_CR1","first-page":"390","volume":"40","author":"AE Edgerton","year":"1942","unstructured":"Edgerton AE: Herpes zoster ophthalmicus: report of cases and a review of the literature. Trans Am Ophthalmol Soc 1942, 40:390\u2013439.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"98_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00417-002-0609-1","volume":"241","author":"MJ Zaal","year":"2003","unstructured":"Zaal MJ, Volker-Dieben HJ, D\u2019Amaro J: Prognostic value of Hutchinson\u2019s sign in acute herpes zoster ophthalmicus. Graefes Arch Clin Exp Ophthalmol 2003, 241:187\u2013191.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"Suppl 1","key":"98_CR3","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1002\/jmv.10364","volume":"70","author":"PE Kilgore","year":"2003","unstructured":"Kilgore PE, Kruszon-Moran D, Seward JF, et al.: Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 2003, 70(Suppl 1):S111\u2013S118.","journal-title":"J Med Virol"},{"key":"98_CR4","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF: Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008, 57:1\u201330.","journal-title":"MMWR Recomm Rep"},{"key":"98_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","volume":"115","author":"TJ Liesegang","year":"2008","unstructured":"Liesegang TJ: Herpes zoster ophthalmicus: natural history, risk factors, clinical presentation, and morbidity. Ophthalmology 2008, 115:S3\u2013S12.","journal-title":"Ophthalmology"},{"key":"98_CR6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan P, et al.: A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007, 82:1341\u20131349.","journal-title":"Mayo Clin Proc"},{"key":"98_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","volume":"24","author":"FT Scott","year":"2006","unstructured":"Scott FT, Johnson RW, Leedham-Green M, et al.: The burden of herpes zoster: a prospective population based study. Vaccine 2006, 24:1308\u20131314.","journal-title":"Vaccine"},{"key":"98_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/510206","volume":"44","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, Johnson RW, Breuer J, et al.: Recommendations for the management of herpes zoster. Clin Infect Dis 2007, 44:S1\u201326.","journal-title":"Clin Infect Dis"},{"key":"98_CR9","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, et al.: Shingles Prevention Study Group: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271\u20132284.","journal-title":"N Engl J Med"},{"key":"98_CR10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0161-6420(86)33678-9","volume":"93","author":"LM Cobo","year":"1986","unstructured":"Cobo LM, Foulks GN, Liesegang T, et al.: Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 1986, 93:763\u2013770.","journal-title":"Ophthalmology"},{"key":"98_CR11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archopht.121.3.386","volume":"121","author":"EA Severson","year":"2003","unstructured":"Severson EA, Baratz KH, Hodge DO, Burke JP: Herpes zoster ophthalmicus in Olmsted County, Minnesota: Have systemic antivirals made a difference?\n                              Arch Ophthalmol 2003, 121:386\u2013390.","journal-title":"Arch Ophthalmol"},{"key":"98_CR12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","volume":"22","author":"MJ Wood","year":"1996","unstructured":"Wood MJ, Kay R, Dworkin RH, et al.: Oral acyclovir therapy accelerates pain resolution in patient with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996, 22:341\u2013347.","journal-title":"Clin Infect Dis"},{"key":"98_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1386-6532(03)00164-1","volume":"29","author":"SD Shafran","year":"2004","unstructured":"Shafran SD, Tyring SK, Ashton R, et al.: Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. J Clin Virol 2004, 29:248\u2013253.","journal-title":"J Clin Virol"},{"key":"98_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","volume":"123","author":"S Tyring","year":"1995","unstructured":"Tyring S, Barbarash RA, Nahlik JE, et al.: Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995, 123:89\u201396.","journal-title":"Ann Intern Med"},{"key":"98_CR15","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0161-6420(00)00222-0","volume":"107","author":"J Colin","year":"2000","unstructured":"Colin J, Prisant O, Cochener B, et al.: Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology 2000, 107:1507\u20131511.","journal-title":"Ophthalmology"},{"key":"98_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/bjo.85.5.576","volume":"85","author":"S Tyring","year":"2001","unstructured":"Tyring S, Engst R, Corriveau C, et al.: Collaborative Famciclovir Ophthalmic Zoster Research Group: Famciclovir for ophthalmic zoster: a randomized acyclovir controlled study. Br J Ophthalmol 2001, 85:576\u2013594.","journal-title":"Br J Ophthalmol"},{"key":"98_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/bmj.294.6567.308-a","volume":"294","author":"CL Leen","year":"1987","unstructured":"Leen CL, Mandal BK, Ellis ME, et al.: Acyclovir and pregnancy. Br Med J 1987, 294:308.","journal-title":"Br Med J"},{"key":"98_CR18","unstructured":"Pregnancy safety index. In Singapore MIMS 121st edition. Edited by Leong WF, Liza FE, Ruby DP, et al. Medical Information Management System (MIMS); 2010:A1\u2013A13."},{"issue":"2 Suppl","key":"98_CR19","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.ophtha.2007.10.012","volume":"115","author":"D Pavan-Langston","year":"2008","unstructured":"Pavan-Langston D: Herpes zoster antivirals and pain management. Ophthalmology 2008, 115(2 Suppl):S13\u2013S20.","journal-title":"Ophthalmology"},{"key":"98_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2165\/00003495-200059060-00009","volume":"59","author":"D Ormrod","year":"2000","unstructured":"Ormrod D, Goa K: Valaciclovir: a review of its use in the management of herpes zoster. Drugs 2000, 59:1317\u20131340.","journal-title":"Drugs"},{"key":"98_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1386-6532(03)00005-2","volume":"26","author":"G Gross","year":"2003","unstructured":"Gross G, Schofer H, Wassilew S, et al.: Herpes zoster guideline of German Dermatology Society (DDG). J Clin Virol 2003, 26:277\u2013289.","journal-title":"J Clin Virol"},{"key":"98_CR22","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0161-6420(94)31142-0","volume":"101","author":"RE Engstrom Jr","year":"1994","unstructured":"Engstrom Jr RE: Holland GN, Margolis TP, et al.: The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology 1994, 101:1488\u20131502.","journal-title":"Ophthalmology"},{"key":"98_CR23","first-page":"384","volume":"22","author":"KW Purdy","year":"2003","unstructured":"Purdy KW, Heckenlively JR, Church JA, et al.: Progressive outer retinal necrosis caused with varicella-zoster virus in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 2003, 22:384\u2013386.","journal-title":"Pediatr Infect Dis J"},{"key":"98_CR24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJM199403313301304","volume":"330","author":"MJ Wood","year":"1994","unstructured":"Wood MJ, Johnson RW, McKendrick MW, et al.: A randomized trial of acyclovir for 7\u00a0days or 21\u00a0days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994, 330:896\u2013900.","journal-title":"N Engl J Med"},{"key":"98_CR25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-125-5-199609010-00004","volume":"125","author":"RJ Whitley","year":"1996","unstructured":"Whitley RJ, Weiss H, Gnann Jr JW: et al.: Acyclovir with and without prednisolone for the treatment of herpes zoster: a randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996, 125:376\u2013383.","journal-title":"Ann Intern Med"},{"key":"98_CR26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/01.WNL.0000140708.62856.72","volume":"63","author":"RM Dubinsky","year":"2004","unstructured":"Dubinsky RM, Kabbani H, El-Chami Z, et al.: Practice parameter: treatment of postherpetic neuralgia. An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004, 63:959\u2013965. Available at http:\/\/www.neurology.org\/cgi\/content\/full\/63\/6\/959.","journal-title":"Neurology"},{"key":"98_CR27","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","volume":"50","author":"CP Watson","year":"1998","unstructured":"Watson CP, Babul N: Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998, 50:1837\u20131841.","journal-title":"Neurology"},{"key":"98_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0304-3959(03)00020-4","volume":"104","author":"F Boureau","year":"2003","unstructured":"Boureau F, Legallicier P, Kabir-Ahmadi M: Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo controlled trial. Pain 2003, 104:323\u2013331.","journal-title":"Pain"},{"key":"98_CR29","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","volume":"51","author":"CP Watson","year":"1998","unstructured":"Watson CP, Vernich L, Chipman M, et al.: Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998, 51:1166\u20131171.","journal-title":"Neurology"},{"key":"98_CR30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","volume":"59","author":"SN Raja","year":"2002","unstructured":"Raja SN, Haythornthwaite JA, Pappagallo M, et al.: Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002, 59:1015\u20131021.","journal-title":"Neurology"},{"key":"98_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","volume":"94","author":"ACS Rice","year":"2001","unstructured":"Rice ACS, Maton S: Gabapentin in postherpetic neuralgia: a randomized, double-blind, placebo controlled study. Pain 2001, 94:215\u2013224.","journal-title":"Pain"},{"key":"98_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00003495-200565010-00011","volume":"65","author":"JE Frampton","year":"2005","unstructured":"Frampton JE, Foster RH: Pregabalin: in the treatment of postherpetic neuralgia. Drugs 2005, 65:111\u2013118; discussion 119\u2013120.","journal-title":"Drugs"},{"key":"98_CR33","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1212\/WNL.39.8.1132-a","volume":"39","author":"I Kissin","year":"1989","unstructured":"Kissin I, McDanal J, Xavier AV: Topical lidocaine for relief of superficial pain in postherpetic neuralgia. Neurology 1989, 39:1132\u20131133.","journal-title":"Neurology"},{"key":"98_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0304-3959(89)90044-4","volume":"39","author":"PJ Stow","year":"1989","unstructured":"Stow PJ, Glynn CJ, Minor B: EMLA cream in the treatment of postherpetic neuralgia. Efficacy and pharmacokinetic profile. Pain 1989, 39:301\u2013305.","journal-title":"Pain"},{"key":"98_CR35","first-page":"510","volume":"15","author":"CP Watson","year":"1993","unstructured":"Watson CP, Tyler KL, Bickers DR, et al.: A randomized vehicle-controlled trial of topical capsaicin in the treatment of post herpetic neuralgia. Clin Ther 1993, 15:510\u2013526.","journal-title":"Clin Ther"},{"key":"98_CR36","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2165\/00003495-200464090-00002","volume":"64","author":"PS Davies","year":"2004","unstructured":"Davies PS, Galer BS: Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004, 64:937\u2013947.","journal-title":"Drugs"},{"key":"98_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/00008480-200402000-00015","volume":"16","author":"M Vazquez","year":"2004","unstructured":"Vazquez M: Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine. Curr Opin Pediatr 2004, 16:80\u201384.","journal-title":"Curr Opin Pediatr"},{"key":"98_CR38","unstructured":"Zostavax prescribing information. Merck & Co.; Whitehouse Station, NJ: December 2009."},{"key":"98_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0304-3959(83)90167-7","volume":"17","author":"GT Lewith","year":"1983","unstructured":"Lewith GT, Field J, Machin D: Acupuncture compared with placebo in postherpetic pain. Pain 1983, 17:361\u2013368.","journal-title":"Pain"},{"key":"98_CR40","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJM200011233432102","volume":"343","author":"N Kotani","year":"2000","unstructured":"Kotani N, Kushikata T, Hashimoto H, et al.: Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000, 343:1514\u20131519.","journal-title":"N Engl J Med"},{"key":"98_CR41","first-page":"2622","volume":"43","author":"M Yamada","year":"2002","unstructured":"Yamada M, Ogata M, Kawai M, et al.: Substance P and its metabolites in normal human tears. Invest Ophthalmol Vis Sci 2002, 43:2622\u20132625.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"98_CR42","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0002-9394(00)00415-3","volume":"129","author":"M Yamada","year":"2000","unstructured":"Yamada M, Ogata M, Kawai M, et al.: Decreased substance P concentrations in tears from patients with corneal hypoesthesia. Am J Ophthalmol 2000, 129:671\u2013672.","journal-title":"Am J Ophthalmol"},{"key":"98_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1097-4652(199610)169:1<159::AID-JCP16>3.0.CO;2-8","volume":"169","author":"T Nishida","year":"1996","unstructured":"Nishida T, Nakamura M, Ofuji K, et al.: Synergistic effects of substance P with insulin-like growth factor-1 on corneal epithelial migration of the cornea. J Cell Physiol 1996, 169:159\u2013166.","journal-title":"J Cell Physiol"},{"key":"98_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1076\/ceyr.16.3.275.15409","volume":"16","author":"M Nakamura","year":"1997","unstructured":"Nakamura M, Ofuji K, Chikama T, et al.: Combined effect of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbits in vivo. Curr Eye Res 1997, 16:275\u2013278.","journal-title":"Curr Eye Res"},{"key":"98_CR45","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/bjo.2007.130013","volume":"92","author":"N Yamada","year":"2008","unstructured":"Yamada N, Matsuda R, Morishige N, et al.: Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy. Br J Ophthalmol 2008, 92:896\u2013900.","journal-title":"Br J Ophthalmol"},{"key":"98_CR46","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(99)04198-7","volume":"354","author":"N Morishige","year":"1999","unstructured":"Morishige N, Komatsubara T, Chikama T, et al.: Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy. Lancet 1999, 354:1613\u20131614.","journal-title":"Lancet"},{"key":"98_CR47","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/archophthalmol.2010.53","volume":"128","author":"SP Dunn","year":"2010","unstructured":"Dunn SP, Heidemann DG, Chow CYC, et al.: Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4. Arch Ophthalmol 2010, 128:636\u2013638.","journal-title":"Arch Ophthalmol"},{"key":"98_CR48","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ophtha.2007.10.013","volume":"115","author":"D Pavan-Langston","year":"2008","unstructured":"Pavan-Langston D, Dohlman CH: Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology 2008, 115:S21\u2013S23.","journal-title":"Ophthalmology"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-010-0098-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0098-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:57:52Z","timestamp":1659095872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-010-0098-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1007\/s11940-010-0098-1","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,12]]},"assertion":[{"value":"12 October 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}